These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
107 related items for PubMed ID: 1796912
21. The effect of human recombinant erythropoietin on iron absorption and hepatic iron in a rat model. Adams PC, Chau LA, Lin E, Muirhead N. Clin Invest Med; 1991 Oct; 14(5):432-6. PubMed ID: 1742921 [Abstract] [Full Text] [Related]
22. Comparison of relevant biological assays for the determination of biological active erythropoietin. Krumwieh D, Arnold I, Seiler FR. Dev Biol Stand; 1988 Oct; 69():15-22. PubMed ID: 3224764 [Abstract] [Full Text] [Related]
23. A sensitive and specific erythropoietin immunoprecipitation assay: application to pharmacokinetic studies. Widness JA, Schmidt RL, Veng-Pedersen P, Modi NB, Sawyer ST. J Lab Clin Med; 1992 Mar; 119(3):285-94. PubMed ID: 1311741 [Abstract] [Full Text] [Related]
25. Expression and characterization of erythropoietin receptors on normal human bone marrow cells. Hoshino S, Teramura M, Takahashi M, Motoji T, Oshimi K, Ueda M, Mizoguchi H. Int J Cell Cloning; 1989 May; 7(3):156-67. PubMed ID: 2543713 [Abstract] [Full Text] [Related]
27. Effect of the interaction between transforming growth factor beta and erythropoietin on the proliferation of normal erythroid progenitors and leukemic UT-7 cells: action of transforming growth factor beta on the erythropoietin receptor. Leveque E, Nagel MD, Haye B. Hematol Oncol; 1996 Sep; 14(3):137-46. PubMed ID: 9119358 [Abstract] [Full Text] [Related]
30. Recombinant human erythropoietin (rh-Epo) administration to normal child bone marrow donors. Martínez AM, Sastre A, Muñoz A, Badell I, Maldonado MS, Cubells J. Bone Marrow Transplant; 1998 Jul; 22(2):137-8. PubMed ID: 9707020 [Abstract] [Full Text] [Related]
31. Differences in capillary electrophoresis profiles of urinary and recombinant erythropoietin. De Frutos M, Cifuentes A, Diez-Masa JC. Electrophoresis; 2003 Feb; 24(4):678-80. PubMed ID: 12601737 [Abstract] [Full Text] [Related]
35. Pharmacokinetic and pharmacodynamic studies following percutaneous absorption of erythropoietin micropiles to rats. Ito Y, Shiroyama K, Yoshimitsu J, Ohashi Y, Sugioka N, Takada K. J Control Release; 2007 Aug 28; 121(3):176-80. PubMed ID: 17628163 [Abstract] [Full Text] [Related]
36. Improvement of Fc-erythropoietin structure and pharmacokinetics by modification at a disulfide bond. Way JC, Lauder S, Brunkhorst B, Kong SM, Qi A, Webster G, Campbell I, McKenzie S, Lan Y, Marelli B, Nguyen LA, Degon S, Lo KM, Gillies SD. Protein Eng Des Sel; 2005 Mar 28; 18(3):111-8. PubMed ID: 15820978 [Abstract] [Full Text] [Related]
37. Recombinant human erythropoietin prevents lipopolysaccharide-induced vascular hyporeactivity in the rat. di Villa Bianca Rd, Sorrentino R, Mitidieri E, Marzocco S, Autore G, Thiemermann C, Pinto A, Sorrentino R. Shock; 2009 May 28; 31(5):529-34. PubMed ID: 18838949 [Abstract] [Full Text] [Related]
38. Erythropoietin attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain. Kumral A, Baskin H, Yesilirmak DC, Ergur BU, Aykan S, Genc S, Genc K, Yilmaz O, Tugyan K, Giray O, Duman N, Ozkan H. Neonatology; 2007 May 28; 92(4):269-78. PubMed ID: 17627093 [Abstract] [Full Text] [Related]
39. Mixed-effects modelling of the interspecies pharmacokinetic scaling of pegylated human erythropoietin. Jolling K, Perez Ruixo JJ, Hemeryck A, Vermeulen A, Greway T. Eur J Pharm Sci; 2005 Apr 28; 24(5):465-75. PubMed ID: 15784336 [Abstract] [Full Text] [Related]